ArticleCureus2023
In Vitro Evaluation of Light-Induced Cytotoxic Property: Synergistic Effects of Anthocyanin/Curcumin as a Photosensitizer.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.
- Toluidine Blue and Chlorin-e6 Mediated Photodynamic Therapy in the Treatment of Oral Potentially Malignant Disorders: A Systematic Review.International journal of molecular sciences · 2025Pooled it
- Photodynamic therapy for oral mucosal lesions: photosensitizer evolution, pharmacological mechanisms, and clinical translation.Frontiers in pharmacology · 2026Review
- Comparing the Therapeutic Efficacy of Curcuma Caesia Roxb Over Curcuma Longa in Managing Oral Submucous Fibrosis: A Non-Randomized Clinical Trial.Asian Pacific journal of cancer prevention : APJCP · 2025Article
- The Efficacy of Curcumin-Mediated Photodynamic Therapy in the Treatment of Oral Squamous Cell Carcinoma: A Systematic Review of In Vitro Studies.Life (Basel, Switzerland) · 2025Review
- Translational Research in Oral Lichen Planus: From Laboratory Discoveries to Clinical Applications.Cureus · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPhotodynamic therapy is one of the non-invasive treatment modalities used to treat a wide range of oral mucosal lesions including oral leukoplakia, oral lichen planus, post-radiation-induced oral mucositis, and aphthous ulcerations. High-level laser therapy has also been employed in the management of oral squamous cell carcinomas (OSCCs). Photodynamic therapy includes three major components: photosensitizer, light source, and presence of oxygen. Examples of commonly used photosensitizers are methylene blue; porphyrins; and 5-aminolevulinic acid (5-ALA) with light sources of differing wavelengths such as diode, neon, and argon helium. METHODOLOGY: Anthocyanin extract was prepared from 25 g of Punica granatum diluted with methanol through the flash evaporation method. Curcumin extract was prepared by diluting initially with dimethyl sulfoxide (DMSO) and later with distilled water. Post-preparation, the samples were treated with MCF-7 cells (cancer cell line) and the MTT (mono-tetrazolium salt) test was performed to determine cell viability. Results: The anthocyanin group exhibited cell death of 27%, whereas the curcumin group exhibited cell death of 17%. A group containing a combination of anthocyanin-curcumin exhibited cell death of 30% compared to that of the control group proving to be superior among all the groups.
conclusionAnthocyanin-curcumin proved to have a light cytotoxic property and could be further used in managing various oral mucosal lesions after evaluation of other photophysical properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.